The purpose of the study is to evaluate the safety and effectiveness of the CentriMag ventricular assist system to help pediatric patients who have experienced heart failure during surgery and cannot be removed from cardiac bypass.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
All patients will be treated with the CentriMag device for up to 30 days.
Survival
In patients who recover and do not go on to transplantation or a long-term device: • Survival 30 days after removal of the CentriMag VAS or to discharge, whichever is longer. In patients who do not recover: • Ability to be removed from the CentriMag VAS and survive to induction of anesthesia for implantation of a long-term device or heart transplantation.
Time frame: 30 days after device removal, or, induction of anesthesia for implant of a long-term device or heart transplant
Evaluation of end-organ function
Improvements in measures of end-organ function
Time frame: 30 days after device removal, or, to induction of anesthesia for implant of a long-term device or heart transplant
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.